Invicro   Report issue

For profit Phase 1 Phase 2
Founded: Boston MA United States (2008)

Organization Overview

First Clinical Trial
2017
NCT03472313
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Invicro